Levocetirizina Krka (Levocetirizine Dihydrochloride)

Levocetirizine selectively blocks peripheral H1 histamine receptors. By preventing histamine from binding to these receptors, it stops the cascade that causes vasodilation, increased vascular permeability, and nerve stimulation, thereby reducing the classic signs of an allergic response such as itching, swelling, and mucus production.

The appropriate dose of Levocetirizina Krka is determined by the prescribing healthcare professional based on the patient’s age, renal function, and severity of symptoms. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data in pregnancy and lactation are limited. Levocetirizine should only be used during pregnancy or while breastfeeding if the potential benefit justifies any possible risk to the fetus or infant, and this decision must be made by a qualified healthcare provider.

To place an order, submit an enquiry on the Levocetirizina Krka product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Levocetirizine is a second‑generation antihistamine that offers effective allergy relief with a lower incidence of sedation compared with first‑generation agents such as diphenhydramine. Its rapid onset and once‑daily dosing make it a convenient alternative to other second‑generation antihistamines, though individual response may vary.

Levocetirizina Krka tablets should be stored at room temperature, below 25 °C, in the original packaging. Keep the product away from moisture, direct sunlight and excessive heat to maintain its stability and potency.

The medication is taken orally, usually with or without food, as a single tablet per day. Patients should swallow the tablet whole with a glass of water and follow the dosing schedule prescribed by their healthcare professional.

Serious but rare risks include angioedema, severe skin reactions such as Stevens‑Johnson syndrome, anaphylaxis, and significant hepatic enzyme elevations. Any signs of swelling, rash, or difficulty breathing require immediate medical attention.

Levocetirizina Krka should be avoided in individuals with known hypersensitivity to levocetirizine or other piperazine antihistamines. Caution is also advised for patients with severe renal impairment, and it should be used only under medical supervision during pregnancy or lactation.